Medifast (MED) Misses Q4 EPS by 120c
Tweet
Share
E-mail
Get Alerts MED Hot Sheet
Price: $10.96 -0.54%
Revenue Growth %: -29.3%
Financial Fact:
Other: -2K
Today's EPS Names:
MAYS, CRMT, REPL, More
Revenue Growth %: -29.3%
Financial Fact:
Other: -2K
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Medifast (NYSE: MED) reported Q4 EPS of ($1.65), $1.20 worse than the analyst estimate of ($0.45). Revenue for the quarter came in at $75.1 million versus the consensus estimate of $73.8 million.
For earnings history and earnings-related data on Medifast (MED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
- US sanctions Cuban military bank and mining company
- RBC initiates GE HealthCare as it sees AI-led innovation cycle driving growth
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
